Edition:
United States

Walvax Biotechnology Co Ltd (300142.SZ)

300142.SZ on Shenzhen Stock Exchange

17.68CNY
20 Oct 2017
Change (% chg)

¥0.51 (+2.97%)
Prev Close
¥17.17
Open
¥17.16
Day's High
¥17.74
Day's Low
¥16.98
Volume
15,631,935
Avg. Vol
12,520,234
52-wk High
¥18.25
52-wk Low
¥9.95

Latest Key Developments (Source: Significant Developments)

Walvax Biotechnology to sell entire 51 pct stake in medical firm for 8.5 mln yuan
Wednesday, 18 Oct 2017 05:10am EDT 

Oct 18(Reuters) - Walvax Biotechnology Co Ltd <300142.SZ>:Says it plans to sell entire 51 percent stake in a Yunnan-based medical company for 8.5 million yuan.  Full Article

Walvax Biotechnology shareholder raises 1.7 pct stake in co
Tuesday, 26 Sep 2017 01:19am EDT 

Sept 26(Reuters) - Walvax Biotechnology Co Ltd <300142.SZ> ::* Says its shareholder Yunnan Industrial Investment Group raises 1.7 percent stake and holds 12.1 percent stake in the co.  Full Article

Walvax Biotechnology receives patent
Wednesday, 30 Aug 2017 02:34am EDT 

Aug 30(Reuters) - Walvax Biotechnology Co Ltd <300142.SZ> ::* Says it received patent(No. ZL 2014 1 0391955.4), for method for detecting purity of cpg odn sequence and application of method.  Full Article

Walvax Biotechnology sees FY 2017 H1 net loss to be 41 mln yuan to 46 mln yuan
Friday, 14 Jul 2017 12:15am EDT 

July 14 (Reuters) - Walvax Biotechnology Co Ltd <300142.SZ> ::* Sees FY 2017 H1 net loss to be 41 million yuan to 46 million yuan, compared to net profit of FY 2016 H1(161.9 million yuan).* Says increased sales revenue and R&D investment as main reason for the forecast.  Full Article

Walvax Biotechnology unit receives GMP certificate
Sunday, 23 Apr 2017 10:18pm EDT 

April 24 (Reuters) - Walvax Biotechnology Co Ltd <300142.SZ> ::* Says its wholly owned subsidiary received goods manufacture practice (GMP) certificate from Yunnan Food and Drug Administration .* Certificate issued pneumococcal polysaccharide vaccine manufactured by the unit and the valid period is until April 18, 2022.  Full Article

Walvax Biotechnology sees FY 2017 Q1 net loss to be 25 mln yuan to 30 mln yuan
Monday, 10 Apr 2017 05:25am EDT 

Walvax Biotechnology Co Ltd <300142.SZ> : Sees FY 2017 Q1 net loss to be 25 million yuan to 30 million yuan . Says the net loss of FY 2016 Q1 was 42.1 million yuan .Says that improvement in main business as main reason for the forecast.  Full Article

Walvax Biotechnology returns to net profit in 2016
Friday, 24 Feb 2017 07:07am EST 

Walvax Biotechnology Co Ltd <300142.SZ> :Says prelim 2016 net profit of 72.2 million yuan ($10.51 million) versus net loss of 840.9 million yuan year ago.  Full Article

Walvax Biotechnology raises 598 mln yuan via private placement
Thursday, 13 Oct 2016 01:19am EDT 

Walvax Biotechnology Co Ltd <300142.SZ> :Says it issues 64.9 million new shares via private placement and raises about 598 million yuan in total, for funding acquisition.  Full Article

Walvax Biotechnology's shares to resume trading after adjusting stakes transfer plan
Tuesday, 11 Oct 2016 05:25am EDT 

Walvax Biotechnology Co Ltd <300142.SZ> :Says its shares to resume trading from Oct 12 after adjusting stakes transfer plan.  Full Article

Walvax Biotechnology unit to sell 9 pct stake in biotech firm at 26 mln yuan
Wednesday, 5 Oct 2016 11:07pm EDT 

Walvax Biotechnology Co Ltd <300142.SZ>:Says its unit to sell 9 percent stake in a Jiangsu-based biotechnology firm to a Liaoning-based group firm at price of about 26 million yuan.  Full Article

BRIEF-Investment fund to invest 600 mln yuan in Walvax Biotechnology's unit

* Says an investment fund to invest 600 million yuan ($91.07 million) in company's unit